Secondary

Researchers discover molecule that causes secondary stroke

Scientists at the University of Cincinnati (UC) College of Medicine have discovered the cause of a deadly type of secondary stroke known as cerebral vasospasm. A constriction of the blood vessels in the brain, cerebral vasospasm usually occurs three to 10 days following a massive brain bleed known as hemorrhagic stroke. Sixty percent of patients who survive the initial stroke develop vasos...

Secondary at Biology Products

No data found

Search Secondary biology products at Google

Search Secondary biology products at Yahoo

Search Secondary biology products at Msn

Secondary at Biology Technology

No data found

Search Secondary biology technology at Google

Search Secondary biology technology at Yahoo

Search Secondary biology technology at Msn

Secondary at Biology Definition

Secondary structure

protein. <a href="/ ?...

Secondary metabolite

. In this sense they are "secondary". The function or importance of these compounds to...

Secondary at Biology Dictionary

Secondary xylem

<A href="http:/ / www.emc.maricopa.edu/ faculty/ farab...

Secondary Structure

s are alpha helices and <a href="/ ?q=/ Biology-Dictionary/ beta_she...

Secondary palate

formed by...

Secondary oocyte

s are fertilized...

Secondary metabolite

isms.<...

More>>

Secondary at Medicine News

Severe stenosis may denote risk for secondary strokes

Researchers from Pennsylvania school of medicine have found that patients who had stroke and diagnosed in head of severe stenosis or narrowed arteries in head are in the risk of developing a subsequent stroke. // The result of the study conducted by Professor Scott Kasner and researchers is to be published in the Journal Circulation. This new diagnostic tool may help in early detection...

Survivors of Childhood Cancers at Higher Risk for Secondary Cancer

According to a recent study published in February 21 Journal of the National Cancer Institute; long-term survivors of childhood cancer// are at a higher risk of developing a secondary cancer than the general population. Treatments for childhood cancer have resulted in a current overall cure rate of over 70 percent. Previous studies have shown that these survivors are specifically at a h...

Lymphoblastic Leukemia Survivors at Risk for Secondary Cancer

A new study finds that survivors of acute lymphoblastic leukemia have a significantly increased risk of secondary cancers when compared to the general population. // Acute lymphoblastic leukemia is the most common cancer in children and adolescents, with almost 4,000 new cases diagnosed in the United States each year. It is also one of the most curable pediatric cancers: survival rates f...

Secondary at Medicine Products

Greenberg Secondary Bar

Description:Kit is supplied with four secondary bars. Secondary bars attach to primary bar. Length 12 (305 mm)....
Company:Codman

USA Series DUR-8 Elite Durable Flexible Ureteroscope System with Primary and Secondary Deflection

Description:The ACMI DUR-8 Elite's 8.7 Fr shaft reaches into the body more easily than any comparable scope providing complete intrarenal access, even reaching the lower pole calyces. Its smooth, lubricious outer covering and working channel ease insertion of both scope and instruments. And its patented torque-stable shaft construction, tight-bend radius tip, and active secondary deflection deliver control...
Company:GYRUS ACMI

Antimicrobial Susceptibility-AFB/Mycobacterium tuberculosis Secondary Panel

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

Secondary at Medicine Technology

YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial

- Company Announces Lead Investigator for U.S. Trial - MISSISSAUGA, ON, July 11, 2007 /PRNewswire-FirstCall/ - YMBioSciences Inc. , an oncology company that identifies, developsand commercializes differentiated products for patients worldwide,today announced results of secondary endpoint data from its 99patient, randomized, placebo-controlled, multi-center Phase IIbtrial (DLXLEF-AP4) with...

Repros' Androxal Shows Highly Statistically Significant Positive Effects in Men with Secondary Hypogonadism

THE WOODLANDS, Texas--(BUSINESS WIRE)--Jun 5, 2007 - ReprosTherapeutics Inc. (NasdaqGM:RPRX) announced topline results of asix month U.S. Phase 3 study of Androxal(TM), an oral drug beingdeveloped to restore normal testicular function in men withsecondary hypogonadism. Further, Androxal demonstratesnon-inferiority in all the endpoints of the study, compared toAndrogel(R), a cream which is t...

BDSI Announces Positive Key Secondary Efficacy Endpoint Results for Bema Fentanyl

MORRISVILLE, N.C.--(BUSINESS WIRE)--May 14, 2007 - BioDeliverySciences International, Inc. (Nasdaq: BDSI) announced additionalstatistically significant results with BEMA Fentanyl in cancerpatients with breakthrough pain in its Phase III efficacy clinicaltrial for the product. Results were based on the company's continuing analysis of thesecondary efficacy endpoints from the study. A key s...

Ceragenix Announces Results from Phase IV Study of EpiCeram Meet All Primary and Secondary Endpoints

DENVER--(BUSINESS WIRE)--Apr 24, 2007 - Ceragenix PharmaceuticalsInc. (OTCBB:CGXP) today announced positive results from itspost-clearance marketing study comparing EpiCeram's(TM) efficacy tothat of Cutivate(R) cream, a mid-strength topical steroid in thetreatment of moderate-to-severe atopic dermatitis (AD). The study, which took place at five centers, consisted of 113pediatric patients,...

Randomized Phase III Trial Showed Erbitux Significantly Improved Secondary Endpoints of Progression-Free Survival and Disease Control in Metastatic Colorectal Cancer Patients

- As previously announced, primary endpoint not met; plausiblyconfounded by survival benefit of post-study treatment with ERBITUX- NEW YORK, April 16, 2007 /PRNewswire-FirstCall/ -- ImCloneSystems Incorporated and Bristol-Myers Squibb Company todayannounced detailed results from the EPIC study - a randomized,open-label, multi-center Phase III trial - comparing ERBITUX(R)(Cetuximab) plus...

More>>

Secondary at Medicine Dictionary

Secondary infections

You are here : Hospita...

Secondary amenorrhea

pri...